Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04919811
Title Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC (TRUST-II)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AnHeart Therapeutics Inc.
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Taletrectinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN

Additional content available in CKB BOOST